193 related articles for article (PubMed ID: 12217248)
1. Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease.
Askanas V; Engel WK
Curr Rheumatol Rep; 2002 Oct; 4(5):427-33. PubMed ID: 12217248
[TBL] [Abstract][Full Text] [Related]
2. Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms.
Askanas V; Engel WK
Curr Opin Neurol; 2002 Oct; 15(5):525-31. PubMed ID: 12351995
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology and pathogenesis of inclusion-body myositis.
Askanas V; Engel WK
Microsc Res Tech; 2005 Jul; 67(3-4):114-20. PubMed ID: 16104000
[TBL] [Abstract][Full Text] [Related]
4. Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease.
Askanas V; Engel WK
J Neuropathol Exp Neurol; 2001 Jan; 60(1):1-14. PubMed ID: 11202170
[TBL] [Abstract][Full Text] [Related]
5. Unfolding story of inclusion-body myositis and myopathies: role of misfolded proteins, amyloid-beta, cholesterol, and aging.
Askanas V; Engel WK
J Child Neurol; 2003 Mar; 18(3):185-90. PubMed ID: 12731644
[TBL] [Abstract][Full Text] [Related]
6. Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging.
Askanas V; Engel WK
Scand J Rheumatol; 1998; 27(6):389-405. PubMed ID: 9855208
[TBL] [Abstract][Full Text] [Related]
7. Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging.
Askanas V; Engel WK
Curr Opin Rheumatol; 2003 Nov; 15(6):737-44. PubMed ID: 14569203
[TBL] [Abstract][Full Text] [Related]
8. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis.
Askanas V; Engel WK
Curr Opin Rheumatol; 1998 Nov; 10(6):530-42. PubMed ID: 9812213
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.
Askanas V; Engel WK; Nogalska A
J Neuropathol Exp Neurol; 2012 Aug; 71(8):680-93. PubMed ID: 22805774
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles.
Vattemi G; Engel WK; McFerrin J; Askanas V
J Neurochem; 2003 Jun; 85(6):1539-46. PubMed ID: 12787072
[TBL] [Abstract][Full Text] [Related]
11. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
Askanas V; Engel WK
Curr Opin Rheumatol; 1995 Nov; 7(6):486-96. PubMed ID: 8579968
[TBL] [Abstract][Full Text] [Related]
12. Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy.
Askanas V; Engel WK; Nogalska A
Biochim Biophys Acta; 2015 Apr; 1852(4):633-43. PubMed ID: 25241263
[TBL] [Abstract][Full Text] [Related]
13. Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice.
Askanas V; Engel WK
Am J Pathol; 1998 Dec; 153(6):1673-7. PubMed ID: 9846956
[No Abstract] [Full Text] [Related]
14. Inclusion-body myositis and Alzheimer disease: two sides of the same coin, or different currencies altogether?
Murphy MP; Golde TE
Neurology; 2006 Jan; 66(2 Suppl 1):S65-8. PubMed ID: 16432148
[No Abstract] [Full Text] [Related]
15. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
Askanas V; Engel WK
Neurology; 2006 Jan; 66(2 Suppl 1):S39-48. PubMed ID: 16432144
[TBL] [Abstract][Full Text] [Related]
16. A perspective on sporadic inclusion-body myositis: the role of aging and inflammatory processes.
Finch CE
Neurology; 2006 Jan; 66(2 Suppl 1):S1-6. PubMed ID: 16432135
[TBL] [Abstract][Full Text] [Related]
17. Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle.
Jaworska-Wilczynska M; Wilczynski GM; Engel WK; Strickland DK; Weisgraber KH; Askanas V
Neurology; 2002 Feb; 58(3):438-45. PubMed ID: 11839845
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death.
Schmidt J; Barthel K; Zschüntzsch J; Muth IE; Swindle EJ; Hombach A; Sehmisch S; Wrede A; Lühder F; Gold R; Dalakas MC
Brain; 2012 Apr; 135(Pt 4):1102-14. PubMed ID: 22436237
[TBL] [Abstract][Full Text] [Related]
19. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau.
Askanas V; Engel WK
Presse Med; 2011 Apr; 40(4 Pt 2):e219-35. PubMed ID: 21392932
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers.
Fratta P; Engel WK; McFerrin J; Davies KJ; Lin SW; Askanas V
Am J Pathol; 2005 Aug; 167(2):517-26. PubMed ID: 16049336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
